Artiva Biotherapeutics, Inc. - FORM S-1 - EX-23.1 - April 8, 2021

Attached files

file filename
S-1 - S-1 - Artiva Biotherapeutics, Inc.d76940ds1.htm
EX-10.25 - EX-10.25 - Artiva Biotherapeutics, Inc.d76940dex1025.htm
EX-10.24 - EX-10.24 - Artiva Biotherapeutics, Inc.d76940dex1024.htm
EX-10.23 - EX-10.23 - Artiva Biotherapeutics, Inc.d76940dex1023.htm
EX-10.22 - EX-10.22 - Artiva Biotherapeutics, Inc.d76940dex1022.htm
EX-10.21 - EX-10.21 - Artiva Biotherapeutics, Inc.d76940dex1021.htm
EX-10.20 - EX-10.20 - Artiva Biotherapeutics, Inc.d76940dex1020.htm
EX-10.19 - EX-10.19 - Artiva Biotherapeutics, Inc.d76940dex1019.htm
EX-10.18 - EX-10.18 - Artiva Biotherapeutics, Inc.d76940dex1018.htm
EX-10.17 - EX-10.17 - Artiva Biotherapeutics, Inc.d76940dex1017.htm
EX-10.16 - EX-10.16 - Artiva Biotherapeutics, Inc.d76940dex1016.htm
EX-10.15 - EX-10.15 - Artiva Biotherapeutics, Inc.d76940dex1015.htm
EX-10.14 - EX-10.14 - Artiva Biotherapeutics, Inc.d76940dex1014.htm
EX-10.13 - EX-10.13 - Artiva Biotherapeutics, Inc.d76940dex1013.htm
EX-10.12 - EX-10.12 - Artiva Biotherapeutics, Inc.d76940dex1012.htm
EX-10.11 - EX-10.11 - Artiva Biotherapeutics, Inc.d76940dex1011.htm
EX-10.10 - EX-10.10 - Artiva Biotherapeutics, Inc.d76940dex1010.htm
EX-10.9 - EX-10.9 - Artiva Biotherapeutics, Inc.d76940dex109.htm
EX-10.8 - EX-10.8 - Artiva Biotherapeutics, Inc.d76940dex108.htm
EX-10.3 - EX-10.3 - Artiva Biotherapeutics, Inc.d76940dex103.htm
EX-10.2 - EX-10.2 - Artiva Biotherapeutics, Inc.d76940dex102.htm
EX-10.1 - EX-10.1 - Artiva Biotherapeutics, Inc.d76940dex101.htm
EX-4.2 - EX-4.2 - Artiva Biotherapeutics, Inc.d76940dex42.htm
EX-3.4 - EX-3.4 - Artiva Biotherapeutics, Inc.d76940dex34.htm
EX-3.3 - EX-3.3 - Artiva Biotherapeutics, Inc.d76940dex33.htm
EX-3.2 - EX-3.2 - Artiva Biotherapeutics, Inc.d76940dex32.htm
EX-3.1 - EX-3.1 - Artiva Biotherapeutics, Inc.d76940dex31.htm

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

The Board of Directors

Artiva Biotherapeutics, Inc.:

We consent to the use of our report included herein and to the reference to our firm under the heading “Experts” in the prospectus.

/s/ KPMG

San Diego, California

April 8, 2021